MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q2
hinzugefügt 01.08.2024
Bausch Health Companies DPO 2011-2025 | BHC
DPO Jährlich Bausch Health Companies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 78.1 | 63.8 | 52.3 | 45.3 | 61.2 | 64.4 | 62.6 | 79.9 | 79.2 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 79.9 | 45.3 | 65.2 |
DPO anderer Aktien in der Arzneimittelhersteller
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.19 | - | $ 128 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
58.9 | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.66 | - | $ 1.44 B | Canada |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
DURECT Corporation
DRRX
|
519 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Aurora Cannabis
ACB
|
-807 | $ 4.49 | - | $ 86.3 M | Canada |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Zomedica Corp.
ZOM
|
211 | - | -0.21 % | $ 98 M | USA |
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M | USA |
 |
Emergent BioSolutions
EBS
|
55.8 | $ 12.43 | - | $ 636 M | USA |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | $ 21.59 | - | $ 2.05 B |  France |
 |
Evolus
EOLS
|
29.4 | $ 6.9 | - | $ 428 M | USA |
 |
Harrow Health
HROW
|
189 | $ 50.09 | - | $ 1.63 B | USA |
 |
China Pharma Holdings
CPHI
|
33.4 | $ 1.29 | - | $ 22.5 M |  China |
 |
Organogenesis Holdings
ORGO
|
94 | $ 5.28 | -10.14 % | $ 695 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Rockwell Medical
RMTI
|
20.9 | $ 0.86 | - | $ 20.1 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
775 | $ 4.12 | - | $ 57.9 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 26.51 | - | $ 1.23 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 3.61 | -0.82 % | $ 4.48 M | USA |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
215 | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
62.7 | $ 13.82 | - | $ 1.9 B | USA |
 |
ProPhase Labs
PRPH
|
45.4 | $ 0.52 | - | $ 8.24 M | USA |
 |
Veru
VERU
|
264 | $ 2.4 | 2.56 % | $ 324 M | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
84 | $ 1.68 | - | $ 7.25 M | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
131 | $ 9.94 | 0.42 % | $ 706 M | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 0.59 | -1.34 % | $ 28.2 M | USA |
 |
Tilray
TLRY
|
53 | $ 9.6 | - | $ 5.93 B | Canada |
 |
TherapeuticsMD
TXMD
|
723 | $ 1.74 | 2.35 % | $ 18.2 M | USA |